Vice President, Public Relations
703.838.0033 ext. 393
April 24, 2017
AMGA Supports Aligning Quality and Cost Measurement in CMS Programs;
Cites Importance of Patient Functional Status
Alexandria, VA – AMGA today responded to the Centers for Medicare & Medicaid Services (CMS) request for comments on its December 2016 “Episode-Based Cost Measure Development for the Quality Payment Program” white paper. Episode-based cost measures will be used to determine the Merit-Based Incentive Payment System (MIPS) “cost” component scores.
“Spending on chronic disease, particularly diseases with co-morbidities, is difficult to account for accurately when calculating episode-based spending,” said Chester A. Speed, J.D., LL.M., AMGA vice president, public policy. “Accurate accounting is made more difficult when functional status limitations are ignored, as these drive comparatively greater spending, independent of the disease condition. Functional status needs to be accounted for or factored in as a weight in calculating spending across an episode of care.”
In its letter, AMGA reiterated the importance of correlating quality and costs or calculating value by measuring quality achieved in MIPS relative to costs or spending. “AMGA members are invested and providing high-quality care at the most efficient cost,” Speed said. “Any system based on the value of care provided needs to align quality and cost.”
AMGA’s letter is available on our website.
AMGA is a trade association leading the transformation of health care in America. Representing multispecialty medical groups and integrated systems of care, we advocate, educate, innovate, and empower our members to deliver the next level of high performance health. AMGA is the national voice promoting awareness of our members’ recognized excellence in the delivery of coordinated, high-quality, high-value care. More than 175,000 physicians practice in our member organizations, delivering care to one in three Americans. For more information, visit amga.org